[Retracted] Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis

Table 6

Incidence of postoperative adverse reactions in two cohorts.

	H101-TACE; ()	c-TACE; ()
Vomit			0.526
0	16 (43.2)	24 (32.4)
1	16 (43.2)	37 (50.0)
2	5 (16.2)	13 (17.6)
Abdominal pain			0.185
0	15 (40.5)	17 (23.0)
1	13 (35.1)	36 (48.6)
2	8 (21.6)	15 (20.3)
3	1 (2.7)	6 (8.1)
Fever			0.048
0	4 (10.8)	24 (32.4)
1	17 (45.9)	32 (43.2)
2	12 (32.4)	15 (20.3)
3	4 (10.8)	3 (4.1)